Part 1: Defining unproven cellular therapies.

Srivastava, Alok; Mason, Chris; Wagena, Edwin; Cuende, Natividad; Weiss, Daniel J; Horwitz, Edwin M; Dominici, Massimo

Srivastava, Alok; Mason, Chris; Wagena, Edwin; Cuende, Natividad; Weiss, Daniel J; Horwitz, Edwin M; Dominici, Massimo.

Afiliación

Srivastava A; Center for Stem Cell Research (a unit of inStem, Bengaluru), Department of Hematology, Christian Medical College, Vellore, India. Member at large of the ISCT Presidential Task Force on the Use of Unproven Cellular Therapies. Electronic address: aloks@cmcvellore.ac.in.
Mason C; Advanced Centre for Biochemical Engineering, University College London, London, United Kingdom. Member at large of the ISCT Presidential Task Force on the Use of Unproven Cellular Therapies.
Wagena E; Voorburg, Netherlands. ISCT Europe, Regional Vice President 2014-2016.
Cuende N; Andalusian Initiative for Advanced Therapies, Junta de Andalucía, Sevilla, Spain. Chair, ISCT EU LRA Committee, 2014-2016.
Weiss DJ; Department of Medicine, University of Vermont, Burlington, Vermont, USA. ISCT Chief Scientific Officer 2014-2016. Chair, ISCT Pulmonary Committee 2013-2015.
Horwitz EM; Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Departments of Pediatrics and Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA. ISCT Past President 2010-2012.
Dominici M; Division of Oncology, Laboratory of Cellular Therapy, University of Modena & Reggio Emilia, Modena, Italy. ISCT President 2014-2016. Chair, ISCT Presidential Task Force on the Use of Unproven Cellular Therapies.

Cytotherapy ; 18(1): 117-9, 2016 Jan.

Article en En | MEDLINE | ID: mdl-26719202

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2016 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google